The levels of several other tumor markers, including serum CA19-9, CA24-2, and cytologic CYFRA were significantly associated with EGFR mutations in NSCLC or lung adenocarcinoma [49, 50]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.